Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

NCT00739141 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndrome
Non-Hodgkins Lymphoma
Chronic Myelogenous Leukemia
Hodgkins Lymphoma

Interventions

DRUG: fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft

Sponsor

Memorial Sloan Kettering Cancer Center